Victory Capital Management Inc. Boosts Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Victory Capital Management Inc. increased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 68.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 413,732 shares of the company’s stock after buying an additional 168,819 shares during the period. Victory Capital Management Inc.’s holdings in HealthEquity were worth $27,430,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in HQY. McGlone Suttner Wealth Management Inc. acquired a new position in shares of HealthEquity during the fourth quarter worth about $29,000. DekaBank Deutsche Girozentrale purchased a new position in HealthEquity in the third quarter worth approximately $41,000. Fifth Third Bancorp grew its holdings in HealthEquity by 36.5% during the 3rd quarter. Fifth Third Bancorp now owns 602 shares of the company’s stock worth $44,000 after acquiring an additional 161 shares in the last quarter. Operose Advisors LLC purchased a new stake in shares of HealthEquity in the 3rd quarter valued at approximately $44,000. Finally, Covestor Ltd raised its holdings in shares of HealthEquity by 92.9% in the 3rd quarter. Covestor Ltd now owns 1,119 shares of the company’s stock valued at $82,000 after purchasing an additional 539 shares in the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Price Performance

HQY stock opened at $80.38 on Wednesday. The company has a current ratio of 4.76, a quick ratio of 4.76 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $6.90 billion, a P/E ratio of 125.59, a PEG ratio of 1.28 and a beta of 0.55. The business has a 50 day simple moving average of $80.66 and a 200-day simple moving average of $74.72. HealthEquity, Inc. has a twelve month low of $53.15 and a twelve month high of $84.49.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, beating the consensus estimate of $0.42 by $0.08. HealthEquity had a net margin of 5.57% and a return on equity of 6.91%. The firm had revenue of $262.39 million during the quarter, compared to the consensus estimate of $258.56 million. As a group, equities analysts anticipate that HealthEquity, Inc. will post 2.12 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on the stock. Barrington Research reiterated an “outperform” rating and set a $100.00 target price on shares of HealthEquity in a research note on Friday, March 22nd. BTIG Research increased their price objective on HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a report on Wednesday, March 20th. KeyCorp raised their target price on HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research report on Friday, March 22nd. JMP Securities initiated coverage on HealthEquity in a report on Thursday, April 4th. They issued a “mkt outperform” rating and a $101.00 price target for the company. Finally, Royal Bank of Canada raised their price objective on shares of HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. One investment analyst has rated the stock with a hold rating and eleven have issued a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $96.17.

Insider Activity

In related news, EVP Delano Ladd sold 2,499 shares of the firm’s stock in a transaction dated Friday, February 9th. The stock was sold at an average price of $80.00, for a total transaction of $199,920.00. Following the transaction, the executive vice president now owns 49,996 shares of the company’s stock, valued at $3,999,680. The transaction was disclosed in a filing with the SEC, which is accessible through this link. In other HealthEquity news, Director Evelyn S. Dilsaver sold 32,500 shares of the company’s stock in a transaction on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the completion of the transaction, the director now owns 32,123 shares in the company, valued at approximately $2,547,032.67. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Delano Ladd sold 2,499 shares of HealthEquity stock in a transaction dated Friday, February 9th. The shares were sold at an average price of $80.00, for a total transaction of $199,920.00. Following the completion of the sale, the executive vice president now directly owns 49,996 shares in the company, valued at approximately $3,999,680. The disclosure for this sale can be found here. Over the last three months, insiders sold 71,322 shares of company stock valued at $5,682,895. Insiders own 2.70% of the company’s stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.